Özge TURHAN, Dilara İNAN, Rabin SABA, Filiz GÜNSEREN, Latife MAMIKOĞLU

Rinoserebral mukormikoz: Bir olgu sunumu

Rinoserebral mukormikoz nadir ancak sıklıkla ölümcül seyreden, invaziv bir fungal infeksiyondur. Sıklıkla diabetes mellitus, AİDS, yüksek doz kemoterapi alan hematolojik mâlignîteli ve transplantasyon hastaları gibi immunkompromize konaklarda karşımıza çıkmaktadır. Rinoserebral tutulum en sık görülen formdur. Baş ağrısı, göz çevresinde ağrı, burun kenarında siyah lezyon, dudaklarda ve yüzde şişlik yakınmalarıyla başvuran elli yaşında bayan hastaya, fizik muayene, radyolojik görüntüleme ve histopatolojik bulgularla rinoserebral mukormikoz tanısı'konmuştur. Tekrarlanan cerrahi debridmanlar ve yüksek doz antifungal tedaviye rağmen kaybedilen hasta, son derece mortal seyreden rinoserebral mukormikoz olgularına dikkati çekmek amacıyla sunulmuştur.

Anahtar Kelimeler:

Mukormikozis, Diabetes mellitus

Rhinocerebral mucormycosis: A case report

Rhinocerebral mucormycosis is a rare and potentially life-threatening invasive fungal infection which results in high mortality. It is most often found in patients with diabetes mellitus, in patients with leukemia who have been neutropenic for long periods and who have been receiving broad-spectrum antibacterial drugs. Rhinocerebral mucormycosis is the most common form. A 50-year-old woman was admitted to our hospital because of headache, periorbital pain, a necrotic lesion at nares, swelling of the lips and face. Rhinocerebral mucormycosis was diagnosed with physical and radiologic examinations and histopathologic findings. Although the patient was given an antifungal therapy and debrided surgically repeated times, she didn't improve and died. This case was reported to emphasize the rhinocerebral mucormycosis which results in high mortality.

Keywords:

Mucormycosis, Diabetes Mellitus,

PDF

___

1. Cagatay A, Oncu S, Calangu S, Yildirmak T, Ozsut H, Eraksoy H: Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report, BMC Infect Dis 2001;1(1):22.
2. Coşkun H, Heper Y, Hızalan İ, Erişen L, Basut O, Akalın H: Rino-serebral mukormikozis: Üç olgu sunumu, Türk Otolarengoloji Arşivi 2004;42 (1):41-50.
3. Ener B: Mukormikoz etkenleri, “Topçu AW, Söyletir G, Doğanay M (editörler): İnfeksiyon Hastalıkları ve Mikrobiyolojisi, 2. baskı” kitabında s.1829-33, Nobel Tıp Kitapevleri, İstanbul (2002).
4. Jacobs P, Wood L, Du Toit A, Esterhuizen K: Eradication of invasive mucormycosis-effectiveness of the echinocandin FK463, Hematology 2003;8(2):119-23.
5. Mondy KE, Haughey B, Custer PL et al: Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review, Pharmacotherapy 2002;22(4):519-26.
6. Parkyn T, McNinch AW, Riordan T, Mott M: Zygomycosis in relapsed acute leukaemia, J Infect 2000;41(3):265-8.
7. Shi BY, Lan L, Guo H, Tan YF: Concomitant diabetic ketoacidosis and rhinocerebral mucormycosis: report of a case, Chin Med J (Engl) 2004;117(7):1113-5.
8. Sugar AM: Agents of mucormycosis and related species, “Mandell GL, Bennett JE, Dolin R (eds): Principles and Practice of Infectious Disease, 5th ed.” kitabında s.2685-95, Churchill Livingstone, New York (2000).
9. Walsh TJ, Goodman JL, Pappas P et al: Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose study, Antimicrob Agents Chemother 2001;45(12):3487-96.